HIV-1 Broadly Neutralizing Antibody Extracts Its Epitope from a Kinked gp41 Ectodomain Region on the Viral Membrane

Immunity

Volumn 28, Issue 1, 2008, Pages 52-63

  Sun, Zhen Yu J ^a   Oh, Kyoung Joon ^a   Kim, Mikyung ^a,b   Yu, Jessica ^b   Brusic, Vladimir ^a   Song, Likai ^a   Qiao, Zhisong ^a,b   Wang, Jia huai ^a,b   Wagner, Gerhard ^a   Reinherz, Ellis L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

MICROBIO; MOLIMMUNO

Indexed keywords

BROADLY NEUTRALIZING ANTIBODY; EPITOPE; GLYCOPROTEIN GP 41; NEUTRALIZING ANTIBODY; PHENYLALANINE; TRYPTOPHAN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; ELECTRON SPIN RESONANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOGENICITY; MEMBRANE PROXIMAL ECTODOMAIN REGION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIMIAN IMMUNODEFICIENCY VIRUS; SURFACE PLASMON RESONANCE; VIRUS ENVELOPE;

ANTIGENS, VIRAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN STRUCTURE, SECONDARY; SURFACE PLASMON RESONANCE;

EID: 37849000389     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.11.018     Document Type: Article

References (51)

1. Alam S.M., McAdams M., Boren D., Rak M., Scearce R.M., Gao F., Camacho Z.T., Gewirth D., Kelsoe G., Chen P., and Haynes B.F. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J. Immunol. 178 (2007) 4424-4435
2. Altenbach C., Greenhalgh D.A., Khorana H.G., and Hubbell W.L. A collision gradient method to determine the immersion depth of nitroxides in lipid bilayers: application to spin-labeled mutants of bacteriorhodopsin. Proc. Natl. Acad. Sci. USA 91 (1994) 1667-1671
3. Barbato G., Bianchi E., Ingallinella P., Hurni W., Miller M., Ciliberto G., Cortese R., Bazzo R., Shiver J.W., and Pessi A. Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion. J. Mol. Biol. 330 (2003) 1101-1115
4. Binley J.M., Wrin T., Korber B., Zwick M.B., Wang M., Chappey C., Stiegler G., Kunert R., Zolla-Pazner S., Katinger H., et al. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78 (2004) 13232-13252
5. Brügger B., Glass B., Haberkant P., Leibrecht I., Wieland I., Wieland F.T., and Kräusslich H.-G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. USA 103 (2006) 2641-2646
6. Brunel F.M., Zwick M., Cardoso R.M., Nelson J.D., Wilson I.A., Burton D.R., and Dawson P.E. Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody. J. Virol. 80 (2006) 1680-1687
7. Brunger A.T. X-PLOR Version 3.1: A System for X-Ray Crystallography and NMR (1992), Yale University Press, New Haven, CT
8. Cardoso R.M., Zwick M.B., Stanfield R.L., Kunert R., Binley J.M., Katinger H., Burton D.R., and Wilson I.A. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22 (2005) 163-173
9. Cardoso R.M., Brunel F.M., Ferguson S., Zwick M., Burton D., Dawson P.E., and Wilson I.A. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. J. Mol. Biol. 365 (2007) 1533-1544
10. Centers for Disease Control and Prevention (CDC). The global HIV/AIDS pandemic, 2006. MMWR Morb. Mortal. Wkly. Rep. 55 (2006) 841-844
11. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
12. Chou J.J., Kaufman J.D., Stahl S.J., Wingfield P.T., and Bax A. Micelle-induced curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measurement in stretched polyacrylamide gel. J. Am. Chem. Soc. 124 (2002) 2450-2451
13. Cornilescu G., Delaglio F., and Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13 (1999) 289-302
14. Dimitrov A.S., Jacobs A., Finnegan C.M., Stiegler G., Katinger H., and Blumenthal R. Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. Biochemistry 46 (2007) 1398-1401
15. Douek D.C., Kwong P.D., and Nabel G.J. The rational design of an AIDS vaccine. Cell 124 (2006) 677-681
16. Epand R.F., Thomas A., Brasseur R., Vishwanathan S.A., Hunter E., and Epand R.M. Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry 45 (2006) 6105-6114
17. Farahbakhsh Z.T., Altenbach C., and Hubbell W.L. Spin labeled cysteines as sensors for protein-lipid interaction and conformation in rhodopsin. Photochem. Photobiol. 56 (1992) 1019-1033
18. Feng F., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-877
19. Ferentz A.E., and Wagner G. NMR spectroscopy: a multifaceted approach to macromolecular structure. Q. Rev. Biophys. 33 (2000) 29-65
20. Guntert P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278 (2004) 353-378
21. Guntert P., Dotsch V., Wider G., and Wuthrich K. Processing of multi-dimensional NMR data with the new software PROSA. J. Biomol. NMR 2 (1992) 619-629
22. Han Y., Wind-Rotolo M., Yang H.C., Siliciano J.D., and Siliciano R.F. Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5 (2007) 95-106
23. Haynes B.F., Fleming J., St Clair E.W., Katinger H., Stiegler G., Kunert R., Robinson J., Scearce R.M., Plonk K., Staats H.F., et al. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308 (2005) 1906-1908
24. Hollis T., Ichikaw Y., and Ellenberger T. DNA binding and a flip-out mechanism for base excision by the helix-hairpin-helix DNA glycosylase, Escherichia coli AlkA. EMBO J. 19 (2000) 758-766
25. Hubbell W.L., Gross A., Langen R., and Lietzow M.A. Recent advances in site-directed spin labeling of proteins. Curr. Opin. Struct. Biol. 8 (1998) 649-656
26. Ihaka R., and Gentleman R. R: a language for data analysis and graphics. J. Comput. Graph. Statist. 3 (1996) 299-314
27. Keller R.L.J. The Computer and Resonance Assignment Tutorial. First Edition (2004), Cantina Verlag, Goldau, Switzerland
28. Kim M., Qiao Z., Yu J., Montefiori D., and Reinherz E.L. Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state. Vaccine 25 (2007) 5102-5114
29. Korber B., Gaschen B., Yusim K., Thakallapally R., Kesmir C., and Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. 58 (2001) 19-42
30. Law M., Cardoso R.M., Wilson I.A., and Burton D.R. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. J. Virol. 81 (2007) 4272-4285
31. Letvin N.L. Progress and obstacles in the development of an AIDS vaccine. Nat. Rev. Immunol. 6 (2006) 930-939
32. Li M., Gao F., Mascola J.R., Stamatatos L., Polonis V.R., Koutsoukos M., Voss G., Goepfert P., Gilbert P., Greene K.M., et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79 (2005) 10108-10125
33. Lorizate M., Cruz A., Huarte N., Kunert R., Perez-Gil J., and Nieva J.L. Recognition and blocking of HIV-1 gp41 pre-transmembrane sequence by monoclonal 4E10 antibody in a Raft-like membrane environment. J. Biol. Chem. 281 (2006) 39598-39606
34. Munoz-Barroso I., Salzwedel K., Hunter E., and Blumenthal R. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J. Virol. 73 (1999) 6089-6092
35. Nelson J.D., Brunel F.M., Jensen R., Crooks E.T., Cardoso R.M.F., Wang M., Hessell A., Wilson I.A., Binley J.M., Dawson P.E., et al. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 (HIV-1) gp41 recognizes an epitope between those of 2F5 and 4E10. J. Virol. 81 (2007) 4033-4043
36. Ofek G., Tang M., Sambor A., Katinger H., Mascola J.R., Wyatt R., and Kwong P.D. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78 (2004) 10724-10737
37. Oh K.J., Altenbach C., Collier R.J., and Hubbell W.L. Site-directed spin labeling of proteins. Applications to diphtheria toxin. Methods Mol. Biol. 145 (2000) 147-169
38. Pervushin K. Impact of transverse relaxation optimized spectroscopy (TROSY) on NMR as a technique in structural biology. Q. Rev. Biophys. 33 (2000) 161-197
39. Popova A.V., Heyer A.G., and Hincha D.K. Differential destabilization of membranes by tryptophan and phenylalanine during freezing: the roles of a lipid composition and membrane fusion. Biochim. Biophys. Acta 1561 (2002) 109-118
40. Qiao Z., Kim M., Reinhold B., Montefiori D., Wang J.-H., and Reinherz E.L. Design, expression and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration. J. Biol. Chem. 280 (2005) 23138-23146
41. Salzwedel K., West J.T., and Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 73 (1999) 2469-2480
42. Schibli D.J., Montelaro R.C., and Vogel H.J. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry 40 (2001) 9570-9578
43. Schwieters C.D., Kuszewski J.M., Tjandra N., and Clore G.M. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160 (2003) 66-74
44. Shimada I. NMR techniques for identifying the interface of a larger protein-protein complex: cross-saturation and transferred cross-saturation experiments. Methods Enzymol. 394 (2005) 483-506
45. Shin Y.K., and Hubbell W.L. Determination of electrostatic potentials at biological interfaces using electron-electron double resonance. Biophys. J. 61 (1992) 1443-1453
46. Suárez T., Nir S., Goñi F.M., Saéz-Cirión A., and Nieva J.L. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Lett. 477 (2000) 145-149
47. Xu Y.-Y., Gorny M.K., Palker T., Karwowska S., and Zolla-Pazner S. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficieincy virus type 1, using ten human monoclonal antibodies. J. Virol. 65 (1991) 4832-4838
48. Yuste E., Sanford H., Carmody J., Bixby J., Little S., Zwick M., Greenough T., Burton D., Richman D.D., Desrosiers R.C., and Johnson W.E. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J. Virol. 80 (2006) 3030-3041
49. Zanetti G., Briggs J.A.G., Grunewald K., Sattentau Q.J., and Fuller S.D. Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathog. 2 (2006) e83 10.1371/journal.ppat.0020083
50. Zhu P., Liu J., Bess J.J., Chertova E., Lifson J.D., Grise H., Ofek G.A., Taylor K.A., and Roux K.H. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441 (2006) 847-852
51. Zwick M.B., Jensen R., Church S., Wang M., Stiegler G., Kunert R., Katinger H., and Burton D.R. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. J. Virol. 79 (2005) 1252-1261